<h1>Competition approval for acquisition of additional shares enables Naspers Ventures to participate in API Holdings' rights issue.</h1> CCI approved the proposed acquisition by Naspers Ventures B.V. of additional shares in API Holdings Limited by participating in a rights issue under the parties' Term Sheet. The Acquirer is an investment holding subsidiary of the Naspers/Prosus group; the Target is the parent of a healthcare group active in B2B wholesale distribution of pharmaceuticals, diagnostics services and ancillary digital health platforms. A detailed CCI order will follow.